The global testosterone replacement therapy market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.7% during 2023-2028. The increasing prevalence of erectile dysfunction and hypogonadism, especially amongst the geriatric men population, and the growing consumer awareness regarding the availability of testosterone substitute therapies and their several advantages represent some of the key factors driving the market.
Testosterone replacement therapy (TRT) refers to a form of reasonable androgen treatment that helps replenish and improve the indications and symptoms associated with lower testosterone levels in men. It involves the administration of various gels, androderm patches, methyltestosterone capsules, topicals, oral implants, buccal adhesives, boosters, and injectables as some of the standard prescribed therapies. These medications help produce red blood cells (RBCs), maintain strong cardiovascular and endothelial health, improve lean muscles, increase bone density, restore libido, enhance bone mineral density, and develop a sense of well-being. Along with this, they boost cognition and memory, increase energy levels and improve overall sexual functions. Based on these properties, TRT is extensively used by prescribed patients to treat or rectify hypogonadism, autoimmune conditions, low testosterone levels, and erectile dysfunctions.
Testosterone Replacement Therapy Market Trends:
The increasing prevalence of erectile dysfunction and hypogonadism, especially amongst the geriatric men population, due to hypothalamic, pituitary axis dysfunction and testicular failures represents one of the prime factors driving the market growth. Additionally, the rising consumer awareness regarding the availability of testosterone substitute therapies to treat hormonal imbalances and their several advantages are acting as another growth-inducing factor. These treatments lower bad cholesterol levels, decrease the risk of diabetes, reduce body fat and increase the self-esteem of an individual; therefore, TRT is widely recommended to patients suffering from hypogonadism. Moreover, the favorable initiatives being undertaken by regulatory bodies to provide access to diverse TRT diagnostic and treatment solutions and the ongoing approvals of a series of medications by the regulatory authorities are favoring the market growth. In line with this, significant technological advancements, such as the extensive usage of advanced machines to formulate oral undecanoate soft gelatin capsules, are supporting the market growth. Furthermore, the continuous sensitization of the masses by non-governmental organizations (NGOs) regarding the symptoms and treatments of testosterone dysfunction is propelling the market growth. Apart from this, the large-scale product diversification and the extensive research and development (R&D) activities to enhance treatment efficacy are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global testosterone replacement therapy market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, active ingredients, and end user.
Product Type Insights:
- Oral implants
- Gums/Buccal Adhesives
The report has also provided a detailed breakup and analysis of the testosterone replacement therapy market based on the product type. This includes oral implants, injections, patches, creams/gels, gums/buccal adhesives, and others. According to the report, injections represented the largest segment.
Active Ingredients Insights:
- Methyl Testosterone
- Testosterone Cypionate
- Testosterone Undecanoate
- Testosterone Enanthate
A detailed breakup and analysis of the testosterone replacement therapy market based on the active ingredients have also been provided in the report. This includes testosterone, methyl testosterone, testosterone cypionate, testosterone undecanoate, and testosterone enanthate. According to the report, testosterone accounted for the largest market share.
End User Insights:
- Specialty Clinics
The report has also provided a detailed breakup and analysis of the testosterone replacement therapy market based on the end user. This includes hospitals, homecare, specialty clinics, and others. According to the report, specialty clinics represented the largest segment.
- North America
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for testosterone replacement therapy. Some of the factors driving the North America testosterone replacement therapy market included the increasing prevalence of erectile dysfunction and hypogonadism, expanding geriatric population base, and the rising consumer awareness regarding the availability of testosterone substitute therapies.
The report has also provided a comprehensive analysis of the competitive landscape in the global testosterone replacement therapy market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc. (Halozyme Therapeutics), Clarus Therapeutics Inc., Endo International plc, Ferring Pharmaceuticals, Kyowa Kirin Co. Ltd., Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
|Product Types Covered
||Oral implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives, Others
|Active Ingredients Covered
||Testosterone, Methyl Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate
|End Users Covered
||Hospitals, Homecare, Specialty Clinics, Others
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc. (Halozyme Therapeutics), Clarus Therapeutics Inc., Endo International plc, Ferring Pharmaceuticals, Kyowa Kirin Co. Ltd., Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.), etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global testosterone replacement therapy market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global testosterone replacement therapy market?
- What are the key regional markets?
- Which countries represent the most attractive testosterone replacement therapy markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the active ingredients?
- What is the breakup of the market based on the end user?
- What is the competitive structure of the global testosterone replacement therapy market?
- Who are the key players/companies in the global testosterone replacement therapy market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the testosterone replacement therapy market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global testosterone replacement therapy market.
- The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the testosterone replacement therapy industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.